A cost-utility comparison of four first-line medications in painful diabetic neuropathy (Q39311840)

10 September 2017

A cost-utility comparison of four first-line medications in painful diabetic neuropathy (English)

1 reference

10 September 2017

Alec B O'Connor

1

0 references

author name string

Katia Noyes

series ordinal

2

1 reference

PubMed ID

19014205

10 September 2017

Robert G Holloway

series ordinal

3

1 reference

10 September 2017

1 January 2008

1 reference

10 September 2017

1 reference

10 September 2017

26

1 reference

10 September 2017

12

1 reference

10 September 2017

1045-1064

1 reference

https://scigraph.springernature.com/pub.10.2165/0019053-200826120-00007

10 September 2017

0 references

cites work

Diabetic peripheral neuropathy and quality of life.

1 reference

https://api.crossref.org/works/10.2165%2F0019053-200826120-00007

Neuropathic pain: a practical guide for the clinician

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0019053-200826120-00007

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0019053-200826120-00007

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0019053-200826120-00007

Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0019053-200826120-00007

Anticholinergic activity of two tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0019053-200826120-00007

The effects of antidepressants on obstructed and unobstructed gait in healthy elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0019053-200826120-00007

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0019053-200826120-00007

Incorporating quality of evidence into decision analytic modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F0019053-200826120-00007

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

12 December 2020

Economic evaluation of oral treatments for neuropathic pain

1 reference

12 December 2020

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

1 reference

12 December 2020

Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.

1 reference

12 December 2020

Adverse cardiovascular events in antidepressant trials involving high-risk patients: a systematic review of randomized trials.

1 reference

12 December 2020

Epidemiology and treatment of neuropathic pain: the UK primary care perspective

1 reference

12 December 2020

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

1 reference

12 December 2020

A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia

1 reference

12 December 2020

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

12 December 2020

Cyclic antidepressants and the risk of sudden cardiac death

1 reference

12 December 2020

Treatment of depression in patients with heart disease

1 reference

12 December 2020

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

1 reference

12 December 2020

EFNS guidelines on pharmacological treatment of neuropathic pain.

1 reference

12 December 2020

Painful diabetic neuropathy: a cross-sectional survey of health state impairment and treatment patterns

1 reference

12 December 2020

Treatment response in antidepressant-naïve postherpetic neuralgia patients: double-blind, randomized trial

1 reference

12 December 2020

Antidepressant therapy in patients with ischemic heart disease

1 reference

12 December 2020

Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria--a population-based cohort study

1 reference

12 December 2020

Computational methods for probabilistic decision trees.

1 reference

12 December 2020

General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction.

1 reference

12 December 2020

Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial

1 reference

12 December 2020

Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials

1 reference

12 December 2020

A systematic review of the associations between dose regimens and medication compliance

1 reference

12 December 2020

Handling uncertainty in cost-effectiveness models

1 reference

12 December 2020

Duloxetine vs. placebo in patients with painful diabetic neuropathy

1 reference

12 December 2020

Diabetic neuropathy: an intensive review

1 reference

12 December 2020

Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy.

1 reference

12 December 2020

Explicit criteria for determining potentially inappropriate medication use by the elderly. An update

1 reference

12 December 2020

Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease

1 reference

12 December 2020

Inappropriate prescribing for elderly Americans in a large outpatient population

1 reference

12 December 2020

Pharmacologic management of neuropathic pain: evidence-based recommendations

1 reference

12 December 2020

Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain

1 reference

12 December 2020

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

1 reference

12 December 2020

Morphine, gabapentin, or their combination for neuropathic pain.

1 reference

12 December 2020

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

1 reference

12 December 2020

Management of painful diabetic neuropathy

1 reference

12 December 2020

The impact of therapy on quality of life and mood in neuropathic pain: what is the effect of pain reduction?

1 reference

12 December 2020

Prescription drug cost sharing: associations with medication and medical utilization and spending and health.

1 reference

12 December 2020

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

1 reference

12 December 2020

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

1 reference

12 December 2020

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

12 December 2020

Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals

1 reference

12 December 2020

Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents

1 reference

12 December 2020

Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain

1 reference

12 December 2020

Lifetime Risk for Diabetes Mellitus in the United States

1 reference

12 December 2020

Diabetic peripheral neuropathy and depressive symptoms: the association revisited

1 reference

12 December 2020

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease

1 reference

12 December 2020

Clinical practice. Painful sensory neuropathy

1 reference

12 December 2020

Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.

1 reference

12 December 2020

1 reference

12 December 2020

Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.

1 reference

12 December 2020

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

1 reference

12 December 2020

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

1 reference

12 December 2020

1 reference

12 December 2020

Algorithm for neuropathic pain treatment: an evidence based proposal.

1 reference

12 December 2020

Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials

1 reference

12 December 2020

Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care

1 reference

12 December 2020

Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression

1 reference

12 December 2020

10.2165/0019053-200826120-00007

Identifiers

DOI

1 reference

PubMed ID

19014205

Dimensions Publication ID

10 September 2017

0 references

1 reference

PubMed ID

19014205